BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 7883851)

  • 1. Autoimmune endocrine disease induced by recombinant interferon-alpha therapy for chronic active type C hepatitis.
    Imagawa A; Itoh N; Hanafusa T; Oda Y; Waguri M; Miyagawa J; Kono N; Kuwajima M; Matsuzawa Y
    J Clin Endocrinol Metab; 1995 Mar; 80(3):922-6. PubMed ID: 7883851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon-alpha therapy may induce insulin autoantibody development in patients with chronic viral hepatitis.
    di Cesare E; Previti M; Russo F; Brancatelli S; Ingemi MC; Scoglio R; Mazzù N; Cucinotta D; Raimondo G
    Dig Dis Sci; 1996 Aug; 41(8):1672-7. PubMed ID: 8769300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
    Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
    Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Organ-specific autoimmunity and genetic predisposition in interferon-treated HCV-related chronic hepatitis patients.
    Floreani A; Chiaramonte M; Greggio NA; Fabris P; De Lazzari F; Naccarato R; Betterle C
    Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):71-6. PubMed ID: 9615270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibodies during alpha-interferon therapy for chronic hepatitis B.
    Fattovich G; Betterle C; Brollo L; Pedini B; Giustina G; Realdi G; Alberti A; Ruol A
    J Med Virol; 1991 Jun; 34(2):132-5. PubMed ID: 1890413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The risk factor for development of thyroid disease during interferon-alpha therapy for chronic hepatitis C.
    Watanabe U; Hashimoto E; Hisamitsu T; Obata H; Hayashi N
    Am J Gastroenterol; 1994 Mar; 89(3):399-403. PubMed ID: 8122653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of thyroid autoimmunity after administration of recombinant human interferon-alpha 2b for chronic viral hepatitis.
    Chung YH; Shong YK
    Am J Gastroenterol; 1993 Feb; 88(2):244-7. PubMed ID: 8424429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serological markers of autoimmunity in renal transplant patients before and after alpha-interferon therapy for chronic hepatitis C.
    Rostaing L; Oksman F; Izopet J; Baron E; Cisterne JM; Hoff M; Abbal M; Durand D
    Am J Nephrol; 1996; 16(6):478-83. PubMed ID: 8955758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyroid autoimmunity in patients on long term therapy with leukocyte-derived interferon.
    Burman P; Tötterman TH; Oberg K; Karlsson FA
    J Clin Endocrinol Metab; 1986 Nov; 63(5):1086-90. PubMed ID: 2944910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoimmunity against pancreatic islets and other tissues before and after interferon-alpha therapy in patients with hepatitis C virus chronic infection.
    Betterle C; Fabris P; Zanchetta R; Pedini B; Tositti G; Bosi E; de Lalla F
    Diabetes Care; 2000 Aug; 23(8):1177-81. PubMed ID: 10937518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Occurrence and significance of autoantibodies in the course of interferon therapy of chronic hepatitis C].
    Heller J; Musiolik J; Homrighausen A; Sauerbruch T; Spengler U
    Dtsch Med Wochenschr; 1996 Sep; 121(39):1179-83. PubMed ID: 8925742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon alpha treatment of chronic hepatitis C in patients with evidence for co-existent autoimmune dysregulation.
    Van Thiel DH; Molloy PJ; Friedlander L; Kania RJ; Fagiuoli S; Caraceni P; Wright HI; Zuhdi N
    Hepatogastroenterology; 1995; 42(6):900-6. PubMed ID: 8847043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyroid autoimmune disorders in patients with chronic hepatitis C before and during interferon-alpha therapy.
    Marazuela M; García-Buey L; González-Fernández B; García-Monzón C; Arranz A; Borque MJ; Moreno-Otero R
    Clin Endocrinol (Oxf); 1996 Jun; 44(6):635-42. PubMed ID: 8759175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exacerbation of thyroid autoimmunity by interferon alpha treatment in patients with chronic viral hepatitis: our studies and review of the literature.
    Nagayama Y; Ohta K; Tsuruta M; Takeshita A; Kimura H; Hamasaki K; Ashizawa K; Nakata K; Yokoyama N; Nagataki S
    Endocr J; 1994 Oct; 41(5):565-72. PubMed ID: 7889118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcome of interferon-alpha-induced thyroid autoimmunity and prognostic influence of thyroid autoantibody pattern at the end of treatment.
    Carella C; Mazziotti G; Morisco F; Manganella G; Rotondi M; Tuccillo C; Sorvillo F; Caporaso N; Amato G
    J Clin Endocrinol Metab; 2001 May; 86(5):1925-9. PubMed ID: 11344186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of chronic type B hepatitis with recombinant alpha-interferon induces autoantibodies not specific for autoimmune chronic hepatitis.
    Mayet WJ; Hess G; Gerken G; Rossol S; Voth R; Manns M; Meyer zum Büschenfelde KH
    Hepatology; 1989 Jul; 10(1):24-8. PubMed ID: 2737600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Thyroid dysfunction in patients with chronic hepatitis C pre and post treatment with interferon].
    Martín-Vivaldi R; Nogueras F; Quintero D; Espinosa MD; López de Hierro M; Suárez JF; González A
    Rev Esp Enferm Dig; 1996 Jul; 88(7):480-4. PubMed ID: 8924326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Islet cell and thyroid antibody prevalence in patients with hepatitis C virus infection: effect of treatment with interferon.
    Piquer S; Hernández C; Enriquez J; Ross A; Esteban JI; Genescà J; Bonifacio E; Puig-Domingo M; Simó R
    J Lab Clin Med; 2001 Jan; 137(1):38-42. PubMed ID: 11150022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cytokine therapy and the endocrine system: is it necessary to monitor more than the thyroid gland?].
    Schuppert F; Müller-Kunert E; Stöcker W; Bokemeyer C; Schmoll HJ; von zur Mühlen A; Rambusch EG
    Med Klin (Munich); 1996 Feb; 91(2):59-65. PubMed ID: 8850099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoimmunity during alpha-interferon therapy for chronic hepatitis C.
    Yoshikawa M; Sakamoto T; Mitoro A; Mochi T; Tsujii H; Koizumi M; Yoshiji H; Sakaguchi Y; Fukui H; Nakano H
    Gastroenterol Jpn; 1993 May; 28 Suppl 5():109-14. PubMed ID: 8359620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.